Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements
Source: SeekingAlpha
2026-02-12 19:35:10 ET
More on Bio-Rad Laboratories, Inc.
- Bio-Rad Laboratories, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript
- Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth
- Bio-Rad Laboratories, Inc. Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Bio-Rad Laboratories, Inc.
Read the full article on Seeking Alpha
For further details see:
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements
Bio-Rad Laboratories Inc. Class A
NASDAQ: BIO
BIO Trading
11.6% G/L:
$277.66 Last:
219,773 Volume:
$274.72 Open:
BIO Latest News
BIO Stock Data
$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules
